UEMS Medical Specialty

Gastroenterology — Page 2

Precision microbiome interventions, short-chain fatty acid (SCFA) delivery, enteric coating technologies, and gut–brain axis modulation for gastrointestinal and liver health.

28

dossiers

Intracellular Defense & IV-Alternatives

Oxidative Stress Mitigation in Nutraceutical Stability: Packaging and Formulation Strategies

Nutraceutical dosage forms face significant degradation due to oxidative stress, driven by moisture, oxygen, and light. This presents a challenge for maintaining stability across supply-chain conditions and long shelf lives.

AgingProbioticsDrug Stability

Precision Microbiome & Gut-Brain Axis

Enteric Delivery of Butyrate: Overcoming Gastrointestinal Barriers for Vagal Activation

Free butyrate salts dissolve prematurely in the upper gastrointestinal tract, limiting their availability for distal gut signaling. Additionally, their pungent odor and taste present significant challenges for patient adherence in chronic applications.

AgingSerotoninGastrointestinal MicrobiomeFatty Acids, Volatile

Post-GLP-1 Metabolic Optimization

Semaglutide: Gastrointestinal Effects and Post-Discontinuation Weight Regain, 2026

Developing GLP-1 formulations that balance robust metabolic benefits with reduced gastrointestinal side effects and mitigate post-discontinuation weight regain remains a significant challenge. The interplay between appetite modulation, gastrointestinal motility, and adverse event profiles adds complexity to product optimization.

DopamineCardiovascular SystemBrain-Gut AxisGlucagon-Like Peptide 1

Precision Microbiome & Gut-Brain Axis

Gut-Brain Axis in ADHD: Microbiota-Mediated Dopaminergic Pathway Modulation

Developing scientifically validated microbiome-targeted interventions for ADHD involves addressing the challenges of heterogeneity in clinical outcomes and identifying precise microbial mechanisms. Formulating stable, effective probiotics or synbiotics with demonstrated clinical benefits remains a major hurdle.

NeuroinflammationAttention Deficit Disorder with HyperactivityDopamineSerotonin

Custom Formulation Available

Need a Dossier Built Around Your Molecule?

Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.